p = 0.001), and to a lesser extent in PNFA. Despite an overlap between clinical and radiological features of FTLD and AD, marked amygdala atrophy points towards a diagnosis of FTLD, with left greater than right atrophy suggestive of one of the language variants.
Introduction
The frontotemporal lobar degenerations (FTLD) are a group of progressive degenerative disorders associated with focal degeneration of the frontal and temporal lobes. These diseases are a common cause of early-onset dementia [1] and are characterised clinically by early behavioural change, with a relative sparing of episodic memory. FTLD has been subdivided clinically into three main syndromic variants: frontotemporal dementia (FTD), semantic dementia (SD) and progressive non-fl uent aphasia (PNFA) [2] . FTD patients present with early and prominent behavioural problems, including alterations in personality and social conduct. While PNFA and SD are both characterised by prominent and early language defi cits, behavioural features often develop with progression of the syndrome [2] .
Animal and human studies have shown that damage to the amygdala is associated with prominent behavioural changes, including altered dietary habits, prominent oral tendencies and hypersexuality [3, 4] . Emotional agnosia is also a common feature of FTLD [5] and has been associated with amygdala damage [6] . MRI studies have demonstrated signifi cant atrophy of the amygdala in patients with SD [7] [8] [9] [10] and FTD [11] , and pathological studies have shown that the amygdala is one of the most severely affected structures in Pick's disease [3, 12] , an important pathological substrate of FTLD.
Differentiating FTLD from Alzheimer's disease (AD) can be diffi cult and although AD is characterised by early memory decline there may be considerable overlap in clinical features between AD and FTLD, especially in the early stages. Behavioural features are also common in AD [13] . Accurate diagnosis is important since each has a different clinical course and specifi c treatments for AD are now available. While amygdala atrophy has been demonstrated on MRI in AD [14] , it is unclear if it is useful in the differential diagnosis of AD [15] , and there are no volumetric MRI studies comparing amygdala atrophy in all three variants of FTLD to AD. The aim of this study was to investigate amygdala atrophy in all three syndromic variants of FTLD, and to determine whether amygdala atrophy may be useful in the differential diagnosis of FTLD and AD.
Materials and Methods

Subjects
All subjects were recruited retrospectively from a specialist cognitive disorders clinic with ethics committee approval and written consent from all study participants. A detailed history, neurological and general examination, screening blood tests, neuropsychometry, including the Mini-Mental State Examination (MMSE) [16] , and MR imaging had been performed for all subjects. Disease duration was defi ned as the time from fi rst symptom onset to MRI scan. Forty-six patients fulfi lling consensus criteria for FTLD [2] were included. Twenty-two of these patients were diagnosed with FTD (often referred to as frontal variant FTD), 14 with SD, and 10 with PNFA. Post-mortem confi rmation was available in 4 cases (2 Pick's disease and 2 FTLD with ubiquitin-only-immunoreactive neuronal changes). The cohort was age-and gender-matched to 20 patients that fulfi lled the NINCDS-ADRDA criteria for 'probable' AD [17] (8 familial, 12 sporadic), and 17 healthy controls. The control subjects were typical of normal ageing and had no complaints of cognitive impairment or behavioural problems. Exclusion criteria included a history of stroke or dementia. MRI was used to exclude space-occupying lesions, vascular disease and other pathologic conditions; however, the diagnosis of FTLD or AD was made purely on clinical grounds without further reference to MRI. [18] , which allows simultaneous image viewing and outlining of regions in coronal, sagittal and axial orientations. All measurements were performed blind to subject details and the results of any other measurements.
Brain volumes were obtained using a semi-automated iterative three-dimensional morphological technique that has been described previously [18] . The left and right amygdalae were outlined manually starting from the anterior limit, defi ned as the anterior extreme of the temporal stem. Posteriorly the amygdala was defi ned using the border with the lateral ventricle and the alveus. Superiorly the boundary was set anteriorly by a line connecting the inferior point of the lateral fi ssure to the lateral most point of the paramedian cisternae and posteriorly by the superior and lateral borders of the optic tract. Inferolaterally the amygdala was bounded by white matter and medially by the ambient cistern [8] . An intensity threshold of 70% mean brain signal intensity was used for consistent segmentation of cerebrospinal fl uid from brain. Scans were fl ipped about the mid-sagittal plane ensuring that the rater was blinded to left/right orientation. The same rater performed all amygdala measurements; their intra-rater ICC (intra-class correlation coeffi cient) on repeating 12 measurements was 0.98 (95% CI 0.97-1.00); this relates to an average 4% difference between the repeated measurements of volume.
Statistics
All volumes were normalised to total intracranial volume (TIV) to reduce the effect of inter-individual variation in head size [19] . Both amygdala and brain volumes were regressed against TIV in the control group to establish the slope of the relationship with TIV. All volumes in the FTLD, AD and control groups were then standardised to TIV volume using the following equation: sbv = bv -␤ (TIV -meanTIV) sbv = standardised volume, bv = crude volume, ␤ = regression coeffi cient of volume on TIV in controls, mean TIV = mean TIV in the control group.
Amygdala asymmetry score was calculated as follows:
Age, MMSE and volume measurements were compared between groups using the Mann-Whitney U test; average percentage volume changes were reported based on analysis of log volumes. Proportions were compared using the Fisher's exact test. The Wilcoxon signed rank test was used to compare left and right amygdala volumes. Sensitivity and specifi city were calculated from logistic regression and used to determine whether amygdala volume and asymmetry could distinguish between patients with FTLD (and its subgroups) from controls, and secondly, from AD.
Results
There were no signifi cant differences in gender or age distribution between the disease groups and controls, or between the different FTLD diagnostic subgroups ( table  1 ) . There was no signifi cant difference in disease duration between FTLD and AD or between the different FTLD diagnostic subgroups. AD and FTLD groups had similar mean MMSE scores.
TIV-adjusted brain volumes were similarly significantly reduced by 6% (95% CI 3-10%) in AD compared with controls (z = 3.32, p = 0.0009) and 7% (4-11%) in FTLD compared with controls (z = 3.72, p = 0.0002). No signifi cant difference was found between FTLD and AD groups (z = 0.66, p = 0.51, table 2 ). Figure 1 shows examples of representative amygdalae from each group. Compared with controls TIV-adjusted amygdala volumes were signifi cantly reduced by 41% (29-51%) on the left and 33% (22-43%) on the right in the FTLD group, and by 22% (13-31%) on the left and 19% (8-29%) on the right in the AD group. Both left and right amygdala volumes were signifi cantly smaller in the FTLD group than the AD group (left z = 3.21, p = 0.001, right z = 2.50, p = 0.01), even when brain volume was accounted for (left z = 3.07, p = 0.001, right z = 2.36, p = 0.02). Signifi cant amygdala asymmetry was present only in the FTLD group, with left amygdala volumes on average 13% (6-18%) smaller than right (z = 3.47, p ! 0.001, fi g. 2 a). The absolute amygdala asymmetry score in FTLD was 0.20 8 0.18 (mean 8 standard deviation), which was signifi cantly greater than the score for the AD group, 0.11 8 0.07 (z = 1.97, p = 0.04), and the control group, 0.10 8 0.07 (z = 2.03, p = 0.04).
In each of the FTLD subgroups the mean left and right amygdala volumes were signifi cantly smaller than control volumes (p ! 0.007 for all, table 2 ). The SD group had the smallest amygdala volumes, signifi cantly smaller than the AD, FTD and PNFA groups (p ! 0.02 for all, left and right). The left amygdala in the SD group was reduced to less than half the mean control volume; this 59% (51-65%) reduction on the left was signifi cantly greater than the right amygdala volume reduction of 45% (33-54%) of Sensitivity = Percentage of patients with average amygdala measurement at or below the specifi ed cut-off level; specifi city = percentage of patients with average amygdala measurement above the specifi ed cut-off level; C = controls. mean control volume (z = 3.23, p = 0.001). The PNFA group also had asymmetrical amygdala volumes, with greater left-sided atrophy, although this was not significant (z = 1.68, p = 0.09). Symmetrical atrophy was observed in the frontal variant FTD group ( fi g. 2 b).
Average (mean of left and right) amygdala volumes discriminated between FTLD and controls with a specifi city of 88% and a sensitivity of 63% ( ); when amygdala asymmetry was included in this regression analysis, sensitivity increased to 100% whilst keeping the specifi city constant.
Discussion
This study demonstrates that very marked amygdala atrophy occurs in all three syndromic variants of FTLD, as well as in AD. The amygdala volumes and asymmetry scores demonstrated signifi cant differences between FTLD, AD and control groups. In the AD patients both left and right amygdala volumes were similarly reduced by approximately 20% of mean control volume. This is consistent with previous studies that have reported between 14 and 44% loss of amygdala volume in AD patients [14, 15, 20] . However, the FTLD patients, even when taken together as a group, showed an asymmetric pattern of amygdala atrophy with a striking 41% loss of volume in the left amygdala, substantially and signifi cantly more than in the AD patients. Atrophy of the right amygdala was also greater in FTLD than AD. Overall, taking the amygdala measurements on their own they had a sensitivity of 63% and specifi city of 60% in differentiating FTLD and AD.
The most severe amygdala atrophy was seen in the patients with SD, with the mean left amygdala volume being almost 60% lower than that of the control group, and over 40% lower in the right amygdala. When amygdala atrophy and asymmetry were taken into account complete separation of the SD patients from the control group was achieved in our sample and more importantly almost complete separation of SD from AD was possible (sensitivity of 100%; specifi city of 85%). Our fi ndings are in keeping with previous studies demonstrating severe left temporal lobe [7, 10] and amygdala atrophy in SD [8] [9] . Amygdala atrophy was also present in the PNFA and FTD groups, although not greater overall than in the AD group. Unlike the AD patients, the PNFA group appeared to display asymmetry with an estimated 12% greater leftsided damage. These fi ndings are also in keeping with previous MRI studies that reported asymmetric left frontal and temporal lobe atrophy in PNFA [21, 22] and one report of amygdala atrophy at autopsy in PNFA [23] ; however, this is the fi rst MRI study to have looked specifi cally at the amygdala in PNFA. Amygdala atrophy has previously been reported in frontal variant FTD, but to a lesser degree than in AD [11] . However in that study the AD patients were signifi cantly (11 years) older and had longer mean disease duration than the FTD patients.
Damage to the amygdala has been associated with deficits in both social behaviour and in the recognition of emotion from facial expressions (especially fear) [3, 24] . In this study amygdala atrophy was present in all syndromic variants of FTLD, but the SD group were the most severely affected. Diagnostic criteria imply that FTD patients have earlier and more profound behavioural change than SD patients, however, there is increasing evidence that patients with SD can have signifi cant behavioural dyscontrol, and may be commonly misdiagnosed as FTD [25, 26] . Behavioural defi cits such as changes in eating behaviour, repetitive behaviours, compulsive behaviours and aggression for example are common in SD [5, 27] . Furthermore, defi cits in the recognition of emotion from facial expressions have been observed in patients with SD [6] , loss of empathy is a major presenting feature of FTLD (especially SD [5] ) and the emotional reaction of fear is commonly lost in SD patients [5] , suggesting a link to amygdala damage. In fact, an association has been found between the processing of emotions and volume of the amygdala in the temporal variant of FTLD [6] . It is likely that the behavioural defi cits commonly found in FTLD, especially in the FTD and SD variants, may involve a complex distributed network of limbic and paralimbic structures, including the amygdala.
This study assessed amygdala atrophy in a large number of FTLD patients (n = 46), allowing the assessment of atrophy in all three of the syndromic variants of FTLD. Although the numbers of patients was greater than previously reported volumetric MRI studies in FTLD the syndromic groups were still relatively small. The different clinical presentations seen in FTLD make it diffi cult to match disease severity accurately to the AD group. MMSE score is particularly reduced in patients with language diffi culties. Nevertheless, the AD and FTLD subgroups were well matched for disease duration, the patients in-cluded in this study were typical in severity to those presenting to cognitive disorders clinics, and the scans chosen for this study were the fi rst MRIs obtained after the initial presentation at our clinic. Finally, the amygdala is a diffi cult structure to defi ne and measure accurately due to poor grey-white matter boundary defi nition and may be associated with relatively large measurement errors. However, in this study the same observer (J.W.) very carefully delineated each amygdala (intra-rater ICC was 0.98, corresponding to an average 4% difference in volumes between repeated measures, which compares well with previous studies) and the severity of atrophy was such that very signifi cant differences were found despite potential measurement insensitivity.
This study emphasises that different patterns of amygdala atrophy underlie not just differences between AD and FTLD but also the different clinical presentations of FTLD. Whilst amygdala measurements provide high sensitivity and specifi city for the diagnosis of SD; the variability in amygdala volumes may limit the value of amygdala measurements in the differential diagnosis of FTLD and AD. Patterns of atrophy are usually more informative and discriminatory than measurements of single structures [8, 9, 28, 29] . In contrast to the symmetric involvement of the hippocampus and medial temporal lobes seen in AD, disproportionate asymmetric atrophy of the amygdala may indicate FTLD, with left greater than right atrophy suggestive of one of the language variants. Therefore, although amygdala atrophy on its own does not provide complete discriminatory power, disproportionate amygdala atrophy should be considered diagnostically important as part of the general assessment of the pattern of atrophy in patients with cognitive impairment.
